eHealth, Inc. (EHTH) Swoon Rewards Bearish Bettors

eHealth, Inc. (EHTH) is on pace for its worst single-session loss ever

Jan 15, 2015 at 10:36 AM
facebook twitter linkedin


eHealth, Inc. (NASDAQ:EHTH) has shed more than half of its value this morning -- putting the stock on pace for its worst day ever -- after last night forecasting an unexpected 2014 adjusted loss and receiving a price-target cut to $8 from $12 (along with a reaffirmed "sell" rating) at Citigroup. In fact, the stock earlier touched a six-year low of $9.31, and was last seen at $9.70. While shareholders can't be happy, a number of options traders likely are.

Digging deeper, EHTH boasts a Schaeffer's put/call open interest ratio (SOIR) of 2.24, which ranks in the 78th percentile of its annual range. In other words, short-term traders have shown a distinct preference for puts over calls, among options expiring in the next three months.

Short sellers have also been active on EHTH. While short interest dropped 21.2% during the most recent reporting period, 8.2% of the equity's float is still sold short, which would take roughly one week to buy back, at typical daily trading volumes.

These bearish bettors could be poised for additional gains if the brokerage bunch follows in the steps of Citigroup. Despite eHealth, Inc.'s (NASDAQ:EHTH) 84.4% year-over-year deficit, 30% of covering analysts still sport "strong buy" ratings. Also, the stock's consensus 12-month price target of $25.25 represents a premium of roughly 160% to the current perch. In other words, additional downgrades and/or price-target reductions are a possibility.

Daily Chart of EHTH since January 2014

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Master Portfolio Trial
 


 


 
Special Offers from Schaeffer's Trading Partners